Ads

 

Ads

 

Ads

 

World Top 1,000 Companies as of January 2024

World Top 1,000 Companies by Market Cap as of January 2024 from Value.Today

World Top 1,000 Companies by Market Cap as of Jan-05-2024. World Biggest 1,000 Companies by Market Cap as of Jan-05-2024. In 2024 also Apple retained World 1st Rank by Market Cap. Second position is occupied by Microsoft. USA companies got First and second rank positions. Third position is occupied by Saudi Aramco from Saudi Arabia.

World Top 1,000 Companies market cap or net worth as of Jan-05-2024 was 77.29 Trillion USD. Both listed and unlisted companies data is considered.

Yamashin-Filter

World Rank (Jan-05-2024)
19,077
Market Cap (Jan-05-2024)
0.160 Billion USD
World Rank (Jul-30-2023)
19,388
Market Cap (Jul-30-2023)
0.156 Billion USD
World Rank (Dec-25-2022)
16,634
World Rank (Jan-07-2022)
16,634
Market Cap (Jan-07-2022)
0.30 Billion USD
Annual Revenue in USD
138 Million USD
Annual Net Income in USD
7 Million USD
Annual Results for Period Ending
Mar-2021 ending year
Headquarters Country

Taiwan Chinsan Electronic Industrial

World Rank (Jan-05-2024)
19,078
Market Cap (Jan-05-2024)
0.160 Billion USD
World Rank (Jul-30-2023)
19,575
Market Cap (Jul-30-2023)
0.150 Billion USD
World Rank (Dec-25-2022)
19,532
Market Cap (Dec-25-2022)
0.151 Billion USD
World Rank (Jan-07-2022)
18,555
Market Cap (Jan-07-2022)
0.22 Billion USD
Headquarters Country

Atrato Onsite Energy PLC

World Rank (Jan-05-2024)
19,079
World Rank (Jul-30-2023)
19,079
Market Cap (Jul-30-2023)
0.165 Billion USD
World Rank (Dec-25-2022)
18,833
Market Cap (Dec-25-2022)
0.172 Billion USD
World Rank (Jan-07-2022)
18,312
Market Cap (Jan-07-2022)
0.23 Billion USD
Headquarters Country

Tomoe Corporation

World Rank (Jan-05-2024)
19,079
Market Cap (Jan-05-2024)
0.160 Billion USD
World Rank (Jul-30-2023)
19,699
Market Cap (Jul-30-2023)
0.147 Billion USD
World Rank (Dec-25-2022)
20,020
World Rank (Jan-07-2022)
20,020
Market Cap (Jan-07-2022)
0.17 Billion USD
Headquarters Country

Isu Abxis Co. Ltd

World Rank (Jan-05-2024)
19,080
Market Cap (Jan-05-2024)
0.160 Billion USD
World Rank (Jul-30-2023)
20,069
Market Cap (Jul-30-2023)
0.136 Billion USD
World Rank (Dec-25-2022)
20,502
Market Cap (Dec-25-2022)
0.124 Billion USD
Headquarters Country

Semper Paratus Acquisition Corp

World Rank (Jan-05-2024)
19,081
Market Cap (Jan-05-2024)
0.160 Billion USD
World Rank (Jul-30-2023)
18,911
Market Cap (Jul-30-2023)
0.170 Billion USD
World Rank (Dec-25-2022)
12,498
Market Cap (Dec-25-2022)
0.494 Billion USD
Headquarters Country

Minsheng Holdings

World Rank (Jan-05-2024)
19,082
Market Cap (Jan-05-2024)
0.160 Billion USD
World Rank (Jul-30-2023)
19,037
Market Cap (Jul-30-2023)
0.166 Billion USD
World Rank (Dec-25-2022)
15,989
Market Cap (Dec-25-2022)
0.288 Billion USD
World Rank (Jan-07-2022)
16,167
Market Cap (Jan-07-2022)
0.33 Billion USD
Headquarters Country

BV Financial

World Rank (Jan-05-2024)
19,083
Market Cap (Jan-05-2024)
0.160 Billion USD
World Rank (Jul-30-2023)
20,426
Market Cap (Jul-30-2023)
0.127 Billion USD
World Rank (Dec-25-2022)
25,884
World Rank (Jan-07-2022)
25,884
Market Cap (Jan-07-2022)
0.06 Billion USD
Headquarters Country

Naigai Trans Line

World Rank (Jan-05-2024)
19,084
Market Cap (Jan-05-2024)
0.160 Billion USD
World Rank (Jul-30-2023)
18,367
Market Cap (Jul-30-2023)
0.189 Billion USD
World Rank (Dec-25-2022)
19,629
World Rank (Jan-07-2022)
19,629
Market Cap (Jan-07-2022)
0.18 Billion USD
Headquarters Country

Kodiak Sciences

World Rank (Jan-05-2024)
19,085
Market Cap (Jan-05-2024)
0.160 Billion USD
World Rank (Jul-30-2023)
19,561
Market Cap (Jul-30-2023)
0.150 Billion USD
World Rank (Dec-25-2022)
14,429
Market Cap (Dec-25-2022)
0.368 Billion USD
World Rank (Jan-07-2022)
4,108
Market Cap (Jan-07-2022)
3.74 Billion USD
Annual Revenue in USD
0 Million USD
Annual Net Income in USD
-266 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Headquarters Country
Company Profile

Kodiak Sciences is a Clinical Stage Biopharmaceutical company. It is specializing in novel therapeutics to treat chronic and high prevalence ophthalmic diseases. The headquarters is in USA.

Share

Ads